Cargando…

A Pancancer Analysis of the Expression Landscape and Clinical Relevance of Fibroblast Growth Factor Receptor 2 in Human Cancers

Background: Fibroblast growth factor receptor 2 (FGFR2) is frequently altered in tumors and one of the top therapeutic targets in cholangiocarcinoma (CHOL) with FGFR2 fusions. Although there have been several studies on individual tumors, a comprehensive analysis of FGFR2 genetic aberrations and the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Juanni, Hu, Kuan, Huang, Jinzhou, Zhou, Lei, Yan, Yuanliang, Xu, Zhijie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097147/ https://www.ncbi.nlm.nih.gov/pubmed/33968743 http://dx.doi.org/10.3389/fonc.2021.644854

Ejemplares similares

Spectrum of Mesenchymal–Epithelial Transition Aberrations and Potential Clinical Implications: Insights From Integrative Pancancer Analysis
por: Li, Juanni, et al.
Publicado: (2020)

Insights of fibroblast growth factor receptor 3 aberrations in pan-cancer and their roles in potential clinical treatment
por: Li, Juanni, et al.
Publicado: (2021)

CCNF is a potential pancancer biomarker and immunotherapy target
por: Wei, Lifang, et al.
Publicado: (2023)

Integrated analysis of expression, prognostic value and immune infiltration of GSDMs in hepatocellular carcinoma
por: Hu, Kuan, et al.
Publicado: (2021)

ACYP1 Is a Pancancer Prognostic Indicator and Affects the Immune Microenvironment in LIHC
por: Zhou, Lingyi, et al.
Publicado: (2022)

BTB/POZ domain‐containing protein 7/hypoxia‐inducible factor 1 alpha signalling axis modulates hepatocellular carcinoma metastasis
por: Hu, Kuan, et al.
Publicado: (2021)

Prognostic Value and Therapeutic Potential of CBX Family Members in Ovarian Cancer
por: Hu, Kuan, et al.
Publicado: (2022)

GSDMs are potential therapeutic targets and prognostic biomarkers in clear cell renal cell carcinoma
por: Yao, Lei, et al.
Publicado: (2022)

An integrative pan cancer analysis of RET aberrations and their potential clinical implications
por: Zhou, Lei, et al.
Publicado: (2022)

Comprehensive Analysis of YTH Domain Family in Lung Adenocarcinoma: Expression Profile, Association with Prognostic Value, and Immune Infiltration
por: Hu, Kuan, et al.
Publicado: (2021)

ALKBH1-8 and FTO: Potential Therapeutic Targets and Prognostic Biomarkers in Lung Adenocarcinoma Pathogenesis
por: Wu, Geting, et al.
Publicado: (2021)

The novel roles of virus infection-associated gene CDKN1A in chemoresistance and immune infiltration of glioblastoma
por: Hu, Kuan, et al.
Publicado: (2021)

Expression profile and prognostic values of Chromobox family members in human glioblastoma
por: Li, Juanni, et al.
Publicado: (2022)

Prognostic Value of PLXND1 and TGF-β1 Coexpression and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma
por: Li, Juanni, et al.
Publicado: (2021)

Fibroblast Growth Factor Receptor 1-4 Genetic Aberrations as Clinically Relevant Biomarkers in Squamous Cell Lung Cancer
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2022)

Pancancer survival analysis of cancer hallmark genes
por: Nagy, Ádám, et al.
Publicado: (2021)

Pancancer Analysis of the Prognostic and Immunotherapeutic Value of Progestin and AdipoQ Receptor 4
por: Yang, Ziyue, et al.
Publicado: (2022)

Expression and molecular profiles of the AlkB family in ovarian serous carcinoma
por: Cai, Yuan, et al.
Publicado: (2021)

MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
por: Zhang, Xiaoyu, et al.
Publicado: (2021)

Deep learning with multimodal representation for pancancer prognosis prediction
por: Cheerla, Anika, et al.
Publicado: (2019)

Pancancer landscape analysis of the thymosin family identified TMSB10 as a potential prognostic biomarker and immunotherapy target in glioma
por: Xiong, Ye, et al.
Publicado: (2022)

The expression and significance of efferocytosis and immune checkpoint related molecules in pancancer samples and the correlation of their expression with anticancer drug sensitivity
por: Cheng, Lin, et al.
Publicado: (2022)

Fibroblast Growth Factor Receptor 3 Amplified Metastatic Melanoma Treated With Erdafitinib
por: Sarkisian, Saro, et al.
Publicado: (2020)

Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
por: Zhang, Xiaoyu, et al.
Publicado: (2021)

Comprehensive Genomic Profiling of EBV-Positive Diffuse Large B-cell Lymphoma and the Expression and Clinicopathological Correlations of Some Related Genes
por: Zhou, Yangying, et al.
Publicado: (2019)

Alantolactone: A Natural Plant Extract as a Potential Therapeutic Agent for Cancer
por: Cai, Yuan, et al.
Publicado: (2021)

Integrative pan-cancer analysis of MEK1 aberrations and the potential clinical implications
por: Zhou, Zhiyang, et al.
Publicado: (2021)

In the Tumor Microenvironment, ETS1 Is an Oncogenic Immune Protein: An Integrative Pancancer Analysis
por: Wu, Zixuan, et al.
Publicado: (2022)

Diagnostic, Prognostic, and Immunological Roles of FABP4 in Pancancer: A Bioinformatics Analysis
por: Yang, Jing, et al.
Publicado: (2022)

Pancancer analysis of DNA methylation-driven genes using MethylMix
por: Gevaert, Olivier, et al.
Publicado: (2015)

The Oncogenic Role and Immune Infiltration for CARM1 Identified by Pancancer Analysis
por: Liu, Kui, et al.
Publicado: (2021)

Pancancer Analysis of Revealed TDO2 as a Biomarker of Prognosis and Immunotherapy
por: Cui, Jing, et al.
Publicado: (2022)

Pancancer network analysis reveals key master regulators for cancer invasiveness
por: Jethalia, Mahesh, et al.
Publicado: (2023)

A pancancer analysis of the oncogenic role of ZNRF2 in human tumours
por: Shi, Fujie, et al.
Publicado: (2023)

The role of fibroblast growth factor 18 in cancers: functions and signaling pathways
por: Zhou, Yiming, et al.
Publicado: (2023)

An Analysis of BMP1 Associated with m6A Modification and Immune Infiltration in Pancancer
por: Zhou, Yiyi, et al.
Publicado: (2022)

A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancer
por: Kerslake, Rachel, et al.
Publicado: (2021)

Development and validation of cancer-associated fibroblasts-related gene landscape in prognosis and immune microenvironment of bladder cancer
por: Zhang, Meng, et al.
Publicado: (2023)

A pancancer analysis of the carcinogenic role of receptor-interacting serine/threonine protein kinase-2 (RIPK2) in human tumours
por: Zhang, Hanqun, et al.
Publicado: (2022)

The Antitumor Activities of Marsdenia tenacissima
por: Wang, Xiang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lpk9c4vh65l43tdn85u78hie3t